Clinical phase Target cells Vector Gene ClinicalTrials.gov identifier
I Patient's T cells Not specified Anti-CEA Ig NCT00004178
II Patient's T cells Not specified Anti-mesothelin NCT01583686
Not specified Tumor cells HSV GM-CSF NCT00402025
I Tumor cells Plasmid DNA + PEI SST2R+ DCK + UMK NCT01274455
I/II Tumor cells Adenovirus Thymidine kinase NCT00638612
SST2R: Somatostatin receptor subtype 2; DCK: deoxycitidine kinase; UMK: uridylmonophosphaste kinase; PEI: polyethylenimine
Table 2: Ongoing Clinical Trials of Gene Therapy for Pancreatic Cancer.